Abstract: A foam-based seating furniture with an enclosure is provided. The foam-based seating furniture includes main body, a cutout opening formed in the main body, fitted fabric configured to encase the main body, and a removable nesting insert configured to friction fit within the cutout opening. The removable nesting insert can be inserted into the cutout opening, or removed, to provide a myriad of seating arrangements. The main body can be provided in a variety of geometries, including a square with a square removable nesting insert, a circle with a base and a circular removable nesting insert, and a hexagon having a circular nesting insert.

Abstract: A foam-based seat and an enclosure for a foam-based seat is provided. The foam-based seat includes a base, main body, a cutout opening formed in the main body, fitted fabric configured to encase the main body, and a removable nesting insert configured to friction fit within the cutout opening. The removable nesting insert can be inserted into the cutout opening, or removed, to provide a myriad of seating arrangements. The foam-based seat may constitute a variety of geometries, including one embodiment that is square with a square removable nesting insert, and another embodiment that is round with an expanded base and a circular nesting insert. The enclosure for a foam-based seat includes a rigid frame with two ends, an internal opening configured to circumscribe a foam-based seat, and a shelving unit that extends from the two ends of the rigid frame.

Abstract: A phantom system is disclosed that includes a phantom and at least one removable phantom attachment configured to be attached to the phantom so that the phantom system may have an orientation, location and/or anthropomorphic feature identifiable to an imaging device.

Abstract: A foam-based seat and an enclosure for a foam-based seat is provided. The foam-based seat includes a base, main body, a cutout opening formed in the main body, fitted fabric configured to encase the main body, and a removable nesting insert configured to friction fit within the cutout opening. The removable nesting insert can be inserted into the cutout opening, or removed, to provide a myriad of seating arrangements. The foam-based seat may constitute a variety of geometries, including one embodiment that is square with a square removable nesting insert, and another embodiment that is round with an expanded base and a circular nesting insert. The enclosure for a foam-based seat includes a rigid frame with two ends, an internal opening configured to circumscribe a foam-based seat, and a shelving unit that extends from the two ends of the rigid frame.

Abstract: Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.

Abstract: Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.

Abstract: Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.

Abstract: Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.

Abstract: Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.

Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.

Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.

Abstract: A method and apparatus for providing in-band messaging through a video switch or other functional element forming a multiplexed content stream prior to transport processing and/or transmission of the multiplexed content stream via an in-band communications channel.

Abstract: The present invention relates to an optical sub-assembly, i.e. a receiver optical subassembly or a transmitter optical sub-assembly, for use in an optical transceiver device. The optical sub-assembly according to the present invention includes a hermetic ceramic package with a multi-layer ceramic structure providing a unique RF signal and ground structure providing a controlled signal impedance to achieve high signal transmission quality.

Abstract: A high dynamic range integrated (HDRI) receiver includes a variable optical attenuator (VOA) for attenuating an incoming optical signal before the optical signal is directed to a photo-detector for conversion into an electrical signal. An optical block receives the optical signal from an optical fiber and includes optics for directing the optical signal to the VOA, and for directing the optical signal from the VOA to the photo-detector.

Abstract: An apparatus and method for programming a remote programmable logic device. The apparatus comprises a processing system having a first file to second file conversion program stored therein. The processing system receives the first file from a first communications medium and transmits the converted second file through a second communications medium in a format native to the remote programmable logic device. The method comprises sending a first file to a processing system via a first communications medium, converting the first file to a second file in a format native to the remote programmable logic device, and sending the second file in a format native to the remote programmable logic device to the remote programmable logic device via a second communications medium.

Abstract: A high dynamic range integrated (HDRI) receiver includes a variable optical attenuator (VOA) for attenuating an incoming optical signal before the optical signal is directed to a photo-detector for conversion into an electrical signal. An optical block receives the optical signal from an optical fiber and includes optics for directing the optical signal to the VOA, and for directing the optical signal from the VOA to the photo-detector.

Abstract: A fiber tail assembly (FTA) with a micro-lens formed in the fiber tip is used to couple the laser light out of the package and along the fiber. The FTA is soldered at two points where metallized bands are deposited on the fiber pigtail, one at a fiber mount near the diode where it can be soldered into alignment with the laser diode, and two at the snout which forms a feed through the housing and seal for the package. Typically, the FTA is metallized along its entire length within the package. In this invention the two-metallized bands are separated by a region that is unmetallized.

Abstract: The present invention relates to an optical sub-assembly, i.e. a receiver optical subassembly or a transmitter optical sub-assembly, for use in an optical transceiver device. The optical sub-assembly according to the present invention includes a hermetic ceramic package with a multi-layer ceramic structure providing a unique RF signal and ground structure providing a controlled signal impedance to achieve high signal transmission quality.

Abstract: A fiber tail assembly (FTA) with a micro-lens formed in the fiber tip is used to couple the laser light out of the package and along the fiber. The FTA is soldered at two points where metallized bands are deposited on the fiber pigtail, one at a fiber mount near the diode where it can be soldered into alignment with the laser diode, and two at the snout which forms a feed through the housing and seal for the package. Typically, the FTA is metallized along its entire length within the package. In this invention the two-metallized bands are separated by a region that is unmetallized.